Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bow River Capital is a Denver-based private alternative asset management and private equity firm focused on investing in the lower middle market across three main asset classes—private equity, real estate, and software growth equity. The firm manages several funds including its flagship Evergreen Fund and has grown assets under management from under $800 million in 2019 to approximately $3 billion by 2025. It targets investments primarily in the Rocky Mountain West and Southwest regions of the United States ("Rodeo Region"), with portfolio companies spanning infrastructure services, industrials, tech-enabled business services, software/SaaS businesses, and healthcare services[1][2][3][5]. While it invests in some healthcare service companies through its private equity arm[3], it does not directly develop drugs or medical technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bow River Capital.